J M Morales1. Show Affiliations » 1. Servicio de Nefrología, Hospital Doce de Octubre, Madrid. jmorales@h12o.es
Abstract
Entities: Disease
Mesh： See more » AdultAgedAngiogenesis Inhibitors/pharmacologyAngiogenesis Inhibitors/therapeutic useDonor Selection/standardsFemaleHumansImmunocompromised HostImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/pharmacologyImmunosuppressive Agents/therapeutic useIncidenceLymphoproliferative Disorders/epidemiologyLymphoproliferative Disorders/etiologyLymphoproliferative Disorders/virologyMaleMiddle AgedNeoplasms/epidemiologyNeoplasms/etiologyNeoplasms/prevention & controlOrgan Transplantation/adverse effectsRandomized Controlled Trials as TopicReoperationRisk FactorsSarcoma, Kaposi/epidemiologySarcoma, Kaposi/etiologySirolimus/adverse effectsSirolimus/pharmacologySirolimus/therapeutic useSkin Neoplasms/epidemiologySkin Neoplasms/etiologyTOR Serine-Threonine Kinases/antagonists & inhibitorsTissue DonorsTumor Escape
Substances： See more » Angiogenesis InhibitorsImmunosuppressive AgentsMTOR protein, humanTOR Serine-Threonine KinasesSirolimus
Year: 2006 PMID： 17937631
Source DB: PubMed Journal: Nefrologia ISSN： 0211-6995 Impact factor: 2.033